Concepedia

Ashkan Emadi

AE

40

Publications

1.6K

Citations

21

H-Index

2002

Active since

Affiliations

University of Maryland, Baltimore(Current)

U-M Rogel Cancer Center

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Johns Hopkins University

Morgan State University

Ashkan Emadi is an author at University of Maryland, Baltimore specializing in medicine, hematology, and pharmacology.

ORCID

Top concepts

Publications per year

2002–2022

40

Publications

40

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster et al. · Blood · 2020 · 307 citations · Full text

Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations

Ashkan Emadi, Sung Ah Jun, Takashi Tsukamoto et al. · Experimental Hematology · 2013 · 156 citations

, , +6

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

Amir Fathi, Hossein Sadrzadeh, Darrell R. Borger et al. · Blood · 2012 · 122 citations · Full text

Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia

Ashkan Emadi, Rawan Faramand, Brandon Carter‐Cooper et al. · American Journal of Hematology · 2015 · 74 citations · Full text

, , +18

Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study

Farid Rashidi, Stefano Barco, Farin Kamangar et al. · Thrombosis Research · 2020 · 72 citations · Full text

Rows per page

1–5 of 40